StemCells Aktie
WKN DE: A1JCUD / ISIN: US85857R2040
|
30.10.2024 22:04:35
|
Stem, Inc. Q3 Loss Increases, Misses Estimates
(RTTNews) - Stem, Inc. (STEM) reported Loss for its third quarter that increased from last year and missed the Street estimates.
The company's bottom line came in at -$148.3 million, or -$0.91 per share. This compares with -$77.1 million, or -$0.49 per share, in last year's third quarter.
Analysts on average had expected the company to earn -$0.21 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 78.1% to $29.3 million from $133.7 million last year.
Stem, Inc. earnings at a glance (GAAP) :
-Earnings (Q3): -$148.3 Mln. vs. -$77.1 Mln. last year. -EPS (Q3): -$0.91 vs. -$0.49 last year. -Revenue (Q3): $29.3 Mln vs. $133.7 Mln last year.
-Guidance: Next quarter revenue guidance: $45-$65 Mln Full year revenue guidance: $135 - $155 Mln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu StemCells Inc.mehr Nachrichten
| Keine Nachrichten verfügbar. |